Evolent Health, Inc. - Class A Shares (EVH) Technical Analysis
$11.27▲0.99%
Market is closed - opens 7 PM, 01 Jul 2025
Insights
- Evolent Health - Class A Shares is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Evolent Health - Class A Shares stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Evolent Health - Class A Shares stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Evolent Health - Class A Shares stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 73.4 | Sell |
Stochastic | 98.45, 96.59 | Neutral |
Ultimate Oscillator | 74.9 | Sell |
Stochastic Relative Strength Index | 100.0, 100.0 | Neutral |
Moving Average Convergence Divergence | 0.56, 0.22 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.66 | Buy |
20 | 8.97 | Sell |
50 | 9.01 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.98 | Buy |
20 | 9.4 | Buy |
50 | 9.16 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.86 | Buy |
20 | 9.34 | Buy |
50 | 9.22 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 10.84 | Buy |
20 | 10.01 | Buy |
50 | 9.06 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 11.22 | Buy |
20 | 10.66 | Buy |
50 | 9.34 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 11.13 |
Resistance L2 | 11.02 |
Resistance L1 | 10.88 |
Pivot Point | 10.77 |
Support L1 | 10.63 |
Support L2 | 10.52 |
Support L3 | 10.38 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.